robot1234
2021-12-15

It was published on 11 Dec Pfizer Vaccine Has 23% Efficacy Vs. Omicron in South African Lab Study. A two-shot course of Pfizer Inc.’s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa.

Vaccine stocks fell sharply in morning trading as Pfizer is 33% effective in preventing Omicron infection
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

  • ChristKitto
    2021-12-15
    ChristKitto
    PFE seems to be doing well. They have stable approved drugs, strong channels, and billions of dollars in COVID-19-related vaccine and treatment funding. They are using the money to increase promising biotechnology to support their drug development efforts. $60 a share seems to be a 22-year conservative estimate.
    • robot1234: 
      Tks for sharing
    • littlesweetie: 
      nice base build here at 55-56 .... we going higher long-term ... no sellers, only buyers!
  • CatherineGunter
    2021-12-15
    CatherineGunter
    It's just for sale. I've been in and out of Pfizer for a long time, and as you veterans know, this stock can't be as smooth as other virus companies. I would be shocked if the game sold for only $56 and kept it going. It's not fair, but it's true. I wish it could fly, but it won't. When the NVDA goes down, I'm going to buy some, but when it stabilizes, I'll buy it again soon.
  • MyrnaNorth
    2021-12-15
    MyrnaNorth
    Personally, I think FDA will want and need to approve PFE Covid treatment before the holiday so that a wave of omiclones that will almost certainly emerge after the holiday party is in place. I would be shocked if the PFE pill is not approved by December 24th.
  • BaronLyly
    2021-12-15
    BaronLyly
    Given the efficacy of the vaccine, and particularly the results confirmed for their antiviral oral medication, this should be trading much higher. This stock is cheap, particularly in this investment environment, where high multiple stocks are getting shellacked
  • CrystalRose
    2021-12-15
    CrystalRose
    Possible EUA of covid treatment pill by end of year or early next year,Just in time to treat new cases of omicron variant.Soon to be a high demand medication?It will probably take a few months for sales to show up on the earnings statements.
  • MatthewWalter
    2021-12-15
    MatthewWalter
    It is safe to buy a 52-week high. Due to profit-taking, the negative impact is small, but the positive impact is unlimited. No one knows when it will reach its peak.
发表看法
20